$27.47
0.56% yesterday
Nasdaq, Jun 27, 10:17 pm CET
ISIN
US98419J2069
Symbol
XOMA
Sector
Industry

XOMA Corporation Stock price

$27.49
+2.57 10.31% 1M
+1.19 4.52% 6M
+1.21 4.60% YTD
+4.59 20.04% 1Y
+5.60 25.58% 3Y
+5.64 25.81% 5Y
-45.71 62.45% 10Y
-512.51 94.91% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
+0.17 0.62%
ISIN
US98419J2069
Symbol
XOMA
Sector
Industry

Key metrics

Basic
Market capitalization
$329.0m
Enterprise Value
$350.0m
Net debt
$21.0m
Cash
$92.7m
Shares outstanding
12.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
7.41 | 6.76
EV/Sales
7.88 | 7.19
EV/FCF
negative
P/B
3.88
Financial Health
Equity Ratio
37.02%
Return on Equity
-23.55%
ROCE
-7.66%
ROIC
-
Debt/Equity
1.34
Financials (TTM | estimate)
Revenue
$44.4m | $48.7m
EBITDA
$-14.0m | $27.8m
EBIT
$-14.7m
Net Income
$-18.6m | $-6.7m
Free Cash Flow
$-26.8m
Growth (TTM | estimate)
Revenue
664.20% | 70.90%
EBITDA
37.00% | 628.39%
EBIT
35.55%
Net Income
55.84% | 65.27%
Free Cash Flow
-46.98%
Margin (TTM | estimate)
Gross
-
EBITDA
-31.49% | 57.19%
EBIT
-33.18%
Net
-41.87% | -13.77%
Free Cash Flow
-60.32%
More
EPS
$-1.04
FCF per Share
$-2.24
Short interest
1.89%
Employees
13.00
Rev per Employee
$2.19m
Show more

Is XOMA Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

XOMA Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a XOMA Corporation forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a XOMA Corporation forecast:

Buy
80%
Hold
20%

Financial data from XOMA Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
44 44
664% 664%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 39 39
40% 40%
88%
- Research and Development Expense 4.17 4.17
3,108% 3,108%
9%
-14 -14
37% 37%
-31%
- Depreciation and Amortization 0.75 0.75
14% 14%
2%
EBIT (Operating Income) EBIT -15 -15
36% 36%
-33%
Net Profit -19 -19
56% 56%
-42%

In millions USD.

Don't miss a Thing! We will send you all news about XOMA Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

XOMA Corporation Stock News

Neutral
GlobeNewsWire
about 22 hours ago
EMERYVILLE, Calif. and SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) and Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq-CM: TSBX) today announced that they have entered into a definitive merger agreement (“the Merger Agreement”), whereby XOMA Royalty will acquire Turnstone for $0.34 in cash per share of Turnstone common s...
Neutral
GlobeNewsWire
10 days ago
EMERYVILLE, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty's Series A and Series B Cumulative Preferred Stock: Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share.
Neutral
GlobeNewsWire
about one month ago
EMERYVILLE, Calif. and LUND, Sweden, May 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced XOMA Royalty has purchase...
More XOMA Corporation News

Company Profile

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Head office United States
CEO Owen Hughes
Employees 13
Founded 1981
Website www.xoma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today